Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d010b390caaf8032c09dd95c3f88c90a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-201 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-14208 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3592 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3584 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3553 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-502 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-609 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-1401 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-3303 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1408 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-14244 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F8-656 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-172 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1723 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4836 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4839 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14532 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H40-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F8-65 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H40-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-172 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-142 |
filingDate |
2020-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfe9693a754a8f109c3cb89a57db9576 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5496f0e7ba079f0f2e471c4a8d24f944 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fa22a0dfe49d9f5faa24513ef66917b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f51267b3d75aae8991bd517214a0331 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_927150f4c626e88d5b2f3b2922659827 |
publicationDate |
2022-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2020356952-A1 |
titleOfInvention |
Blood glucose control system |
abstract |
A blood glucose control system is configured to modify therapy provide to a subject and determine whether the modified therapy results in a statistically significant improvement in glycemic control. The system obtains glycemic control information resulting from delivery of first therapy using a first value of a control parameter and determines a first effect corresponding to the first therapy. The control parameter is set to a second value that differs from the first value. The system obtains glycemic control information resulting from the delivery of the second therapy using the second value of the control parameter and determines a second effect corresponding to the second therapy. The system can perform a comparative assessment and determine whether the second value for the control parameter results in a statistically significant improvement in glycemic control for the subject. |
priorityDate |
2019-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |